This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Hk Inno.n Corporation. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Ye-Ri Shim: Innovator in Protein Kinase Inhibition
Introduction
Ye-Ri Shim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit protein kinases. His work is crucial in addressing various protein kinase-related diseases.
Latest Patents
Ye-Ri Shim holds a patent for a compound that acts as a protein kinase inhibitor. This invention provides a novel compound with the potential to prevent or treat diseases such as cancers, autoimmune diseases, neurological diseases, metabolic diseases, and infections. The patent emphasizes the effectiveness of the compound, its stereoisomers, and pharmaceutically acceptable salts in exhibiting protein kinase inhibitory activity.
Career Highlights
Ye-Ri Shim is associated with Hk Inno.n Corporation, where he continues to advance his research and development efforts. His innovative approach has positioned him as a key figure in the pharmaceutical industry, particularly in the realm of targeted therapies.
Collaborations
Ye-Ri Shim collaborates with talented individuals such as Ji-Yeon Park and Seung Chan Kim. Their combined expertise enhances the research and development initiatives at Hk Inno.n Corporation.
Conclusion
Ye-Ri Shim's contributions to the field of protein kinase inhibition are noteworthy and have the potential to impact the treatment of various diseases significantly. His innovative spirit and dedication to research continue to drive advancements in pharmaceutical sciences.